参考文献:1.Kransdorf MJ (1995) Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR 164:129–134CrossRef PubMed 2.Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (eds) (2013) WHO classification of tumours of soft tissue and bone. International Agency for Research on Cancer, Lyon 3.Peterson JJ, Kransdorf MJ, Bancroft LW, O’Connor MI (2003) Malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol 32:493–503CrossRef PubMed 4.DeLaney TF (2012) Radiation therapy: neoadjuvant, adjuvant, or not at all. Surg Oncol Clin N Am 21:215–241CrossRef PubMed 5.Haas RLM, DeLaney TF, O’Sullivan B, Keus RB, Le Pechoux C, Olmi P et al (2012) Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? Int J Radiat Oncol Biol Phys 84:572–580CrossRef PubMed 6.DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ et al (2003) Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 56:1117–1127CrossRef PubMed 7.O’Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomized trial. Lancet 359:2235CrossRef PubMed 8.Davis AM, O’Sullivan B, Turcotte R et al (2005) Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75:48CrossRef PubMed 9.Pitson G, Robinson P, Wilke D, Kandel RA, White L, Griffin AM et al (2004) Radiation response: an additional unique signature of myxoid liposarcoma. Int J Radiat Oncol Biol Phys 60:522–526CrossRef PubMed 10.Chung PWM, Deheshi BM, Ferguson PC, Wunder JS, Griffin AM, Catton CN et al (2009) Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas. Cancer 115:3254–3261CrossRef PubMed 11.Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Benjamin RS et al (2008) Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 70:760–765CrossRef PubMed 12.De Vreeze RSA, de Jong D, Haas RL, Stewart F, van Coevorden F (2008) Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern. Int J Rad Oncol Biol Phys 72:1480–1487CrossRef 13.Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216CrossRef PubMed 14.Stacchiotti S, Collini P, Messina A, Morosi C, Barisella M, Bertulli R et al (2009) High-grade soft-tissue sarcomas: tumor response assessment—pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology 251:447–456CrossRef PubMed 15.Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A et al (2012) Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer 118:5857–5866CrossRef PubMed 16.Miki Y, Ngan S, Clark JCM, Akiyama T, Choong PFM (2010) The significance of size change of soft tissue sarcoma during preoperative radiotherapy. Eur J Surg Oncol 36:678–683CrossRef PubMed 17.Engström K, Bergh P, Cederlund C-G, Hultborn R, Willen H, Åman P et al (2007) Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta Oncol 46:838–845CrossRef PubMed 18.Roberge D, Skamene T, Nahal A, Turcotte RE, Powell T, Freeman C (2010) Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma. Radiother Oncol 97:404–407CrossRef PubMed 19.Eilber FC, Rosen G, Eckardt J, Forscher C, Nelson SD, Selch M et al (2001) Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19:3203–3209PubMed 20.Mullen JT, Hornicek FJ, Harmon DC, Raskin KA, Chen YL, Szymonifka J et al (2014) Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy. Cancer 120:3676–3682CrossRef PubMed PubMedCentral 21.Wang W-L, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC et al (2012) Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res 2:25CrossRef PubMed PubMedCentral
作者单位:Jeremy R. Wortman (1) Sree Harsha Tirumani (1) (2) Harika Tirumani (2) (3) Atul B. Shinagare (1) (2) Jyothi P. Jagannathan (1) (2) Jason L. Hornick (4) Nikhil H. Ramaiya (1) (2)
1. Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA 2. Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA 3. Department of Radiology, University of Arkansas Medical Sciences, Little Rock, AR, USA 4. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA
刊物类别:Medicine
刊物主题:Medicine & Public Health Imaging and Radiology Diagnostic Radiology Interventional Radiology Neuroradiology Ultrasound Internal Medicine
出版者:Springer Berlin / Heidelberg
ISSN:1432-1084
文摘
Objective To evaluate MRI features of response of primary extremity liposarcoma (LPS) to neoadjuvant radiation therapy (RT) with histopathologic correlation.